Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

A Simplified Geriatric Assessment (sGA) Can Identify Older Patients with Relapse/Refractory (R/R) Aggressive Lymphoma Suitable for Autologous Stem Cell Transplantation (ASCT): Final Results of Recanz Multicentre Prospective Phase 2 Study By the Fondazione Italiana Linfomi (FIL)

Blood (2021) 138 (Supplement 1): 2496.

https://doi.org/10.1182/blood-2021-149649

Published: 2021

Journal Articles

The Addition of Bortezomib to R-DHAP Does Not Improve the Response Pre-Stem Cell Transplantation Compared to Standard R-DHAP in Young Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Preliminary Results of the Phase II Randomized Trial FIL-VERAL12 of the Fondazione Italiana Linfomi

Blood (2019) 134 (Supplement_1): 2025.

https://doi.org/10.1182/blood-2019-130786

Published: 2019

Journal Articles

Management and Outcome of Patients with Diffuse Large B-Cell Lymphoma Relapsed after Autologous Hemopoietic Stem Cell Transplantation (auto-HSCT): A Retrospective Analysis of the Lymphoma Working Party (LWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Blood (2017) 130 (Supplement 1): 2025.

https://doi.org/10.1182/blood.V130.Suppl_1.2025.2025

Published: 2017

Journal Articles

Autologous Stem Cell Transplantation (autoSCT) for HIV-Associated Lymphoma in the Era of Combination Antiretroviral Therapy (cART): A Retrospective Analysis of the EBMT Lymphoma Working Party

Kai Huebel, MD, Alessandro Re, MD, Ariane Boumendil, PhD, Herve Finel, Marcus Hentrich, Mariagrazia Michieli, Edward Kanfer, Jose Luis Diez-Martin, MD PhD, Pascual Balsalobre, Laure Vincent, Wilfried Schroyens, MD PhD, Josep Maria Ribera Santasusana, Nicolaus Kröger, MD, Xaver Schiel, MD, Kirsty J Thomson, MD, Jorge Sierra, MD, Aida Botelho Sousa, Silvia Montoto, MD, Peter Dreger, MD

Blood (2016) 128 (22): 2257.

https://doi.org/10.1182/blood.V128.22.2257.2257

Published: 2016

Journal Articles

Early Consolidation with High Dose Therapy and Autologous Stem Cell Transplantation in HIV-Associated Non Hodgkin Lymphoma at High Risk (aa-IPI 2-3). Mature Results of a Multicenter Prospective Phase II Trial

Alessandro Re, MD, Chiara Cattaneo, MD, Salvatore Casari, MD, Guido Gini, MD, Mariagrazia Michieli, Bernardino Allione, Luisa Verga, MD, Caterina Bocci, Michele Spina, MD, Stefania Tamiazzo, Alessandra Bandera, Flavia Salvi, MD, Annalisa Peli, MD, Moira Micheletti, Camillo Almici, MD, Pierino Ferremi, Umberto Tirelli, MD, Giuseppe Rossi, MD

Blood (2014) 124 (21): 2528.

https://doi.org/10.1182/blood.V124.21.2528.2528

Published: 2014

Journal Articles

Early Consolidation with High Dose Therapy and Autologous Stem Cell Transplantation in HIV-Associated Non Hodgkin Lymphoma At High Risk (Aaipi 2–3). an Interim Report of a Multicenter Phase II Trial.

Alessandro Re, MD, Mariagrazia Michieli, Bernardino Allione, MD, Salvatore Casari, MD, Chiara Cattaneo, MD, Michele Spina, Andrea Gori, Elisa Garlassi, Luisa Verga, MD, Camillo Almici, MD, Pierino Ferremi, Mario Mazzucato, Alessandro Levis, MD, Umberto Tirelli, MD, Giuseppe Rossi, MD

Blood (2012) 120 (21): 3124.

https://doi.org/10.1182/blood.V120.21.3124.3124

Published: 2012

Journal Articles

Peripheral Blood Stem Cell Mobilization In Hiv Positive Patients with Lymphoma Candidates to Autologous Transplantation: Predictive Factors Analysis for Failure or Suboptimal Stem Cell Collection

Alessandro Re, Pascual Balsalobre, Mariagrazia Michieli, Jose M. Ribera, MD, PhD, Bernardino Allione, Camillo Almici, MD, Pierino Ferremi, Mario Mazzucato, Chiara Cattaneo, Salvatore Casari, Michele Spina, MD, Cristina Skert, Jose L. Diez-Martin, MD, PhD, Umberto Tirelli, Giuseppe Rossi, MD

Blood (2010) 116 (21): 2250.

https://doi.org/10.1182/blood.V116.21.2250.2250

Published: 2010

Journal Articles

Pretransplatation PET as Major Prognostic Discriminant in IGEV (ifosfamide, gemcitabine, vinorelbine and prednisone) Treated Patients with Relapsed/Refractory Hodgkin's Lymphoma (HL).

Rita Mazza, MD, Stefano Luminari, Massimo Magagnoli, MD, Michele Spina, MD, Teodoro Chisesi, MD, Antonio Pinto, MD, Massimo Federico, MD, Antonella Anastasia, MD, Arturo Chiti, MD, Mariagrazia Michieli, MD, Francesco Angrilli, MD, Luca Castagna, Giampaolo Marcacci, Laura Giordano, PhD, Umberto Tirelli, MD, Armando Santoro, Monica Balzarotti

Blood (2009) 114 (22): 3707.

https://doi.org/10.1182/blood.V114.22.3707.3707

Published: 2009

Journal Articles

Conventional Chemotherapy Followed by Consolidation with Autologous Hematopoietic Transplantation Vs Chemotherapy Alone in HIV+ Patients with Large B Cell Lymphoma (LBCL) in First Complete Remission (CR). A Retrospective Analysis On Behalf of the EBMT Lymphoma Working Party and the GESIDA/PETHEMA Registry of HIV+ Patients with Non-Hodgkin's Lymphoma (NHL).

Pascual Balsalobre, BN, Juan Berenguer, MD, PhD, Pilar Miralles, MD, PhD, David Serrano, MD, Josep-Maria Ribera, MD, PhD, Carmen Canals, MD, PhD, Marisa Montes, MD, Mariagrazia Michieli, MD, Eulalia Valencia, MD, Anne Rosselet, MD, Francisco Rodríguez-Arrondo, MD, Philippe Genet, MD, Maria J Galindo, MD, Augustin Ferrant, MD, PhD, Vicente Pintado, MD, Jose M Bellon, Anna Sureda, MD, PhD, Jose L. Diez-Martin, MD, PhD

Blood (2009) 114 (22): 4355.

https://doi.org/10.1182/blood.V114.22.4355.4355

Published: 2009

Journal Articles

High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors

Alessandro Re, Mariagrazia Michieli, Salvatore Casari, Bernardino Allione, Chiara Cattaneo, Maurizio Rupolo, Michele Spina, Rosa Manuele, Emanuela Vaccher, Mario Mazzucato, Luciano Abbruzzese, Pierino Ferremi, Giampiero Carosi, Umberto Tirelli, Giuseppe Rossi

Blood (2009) 114 (7): 1306–1313.

https://doi.org/10.1182/blood-2009-02-202762

Published: 2009

Journal Articles

Comparable survival between HIV + and HIV − non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation

Blood (2009) 113 (23): 6011–6014.

https://doi.org/10.1182/blood-2008-12-195388

Published: 2009

Journal Articles

High Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation as Salvage Therapy for HIV-Associated Lymphoma: Result of the GICAT Study.

Alessandro Re, MD, Mariagrazia Michieli, MD, Chiara Cattaneo, MD, Maurizio Rupolo, MD, Salvatore Casari, MD, Michele Spina, MD, Bernardino Allione, MD, Camillo Almici, MD, Piero Ferremi, MD, Luciano Abruzzese, MD, Cecilia Simonelli, MD, Rosa Manuele, MD, Alessandro Levis, MD, Giampiero Carosi, MD, Umberto Tirelli, MD, Giuseppe Rossi, MD

Blood (2007) 110 (11): 23.

https://doi.org/10.1182/blood.V110.11.23.23

Published: 2007

Journal Articles

Factors Affecting Outcome of Patients with Refractory/Relapsed Hodgkin’s Disease (HD) Treated with IGEV Chemotherapy (CT) and High Dose Consolidation Therapy (HDT) with Stem Cell Rescue.

Monica Balzarotti, MD, Michele Spina, MD, Massimo Magagnoli, MD, Teodoro Chisesi, MD, Antonello Pinto, MD, Luca Castagna, MD, Monica Demarco, MD, Mariagrazia Michieli, MD, Andrea Nozza, MD, Umberto Tirelli, MD, Armando Santoro, MD

Blood (2005) 106 (11): 2091.

https://doi.org/10.1182/blood.V106.11.2091.2091

Published: 2005

Journal Articles

Tymic Output after Autologous Bone Marrow Transplantation (ASCT) HIV-Related Lymphoma.

Cecilia Simonelli, MD, Michele Spina, MD, Chiara Pratesi, ScD, Rosamaria Tedeschi, ScD, Maurizio Rupolo, MD, Maria Teresa Bortolin, ScD, Stefania Zanussi, ScD, Mariagrazia Michieli, MD, Paolo De Paoli, MD, Umberto Tirelli, MD

Blood (2005) 106 (11): 2933.

https://doi.org/10.1182/blood.V106.11.2933.2933

Published: 2005

Journal Articles

Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials

Michele Spina, Ulrich Jaeger, Joseph A. Sparano, Renato Talamini, Cecilia Simonelli, Mariagrazia Michieli, Giuseppe Rossi, Ezio Nigra, Massimiliano Berretta, Chiara Cattaneo, Armin C. Rieger, Emanuela Vaccher, Umberto Tirelli

Blood (2005) 105 (5): 1891–1897.

https://doi.org/10.1182/blood-2004-08-3300

Published: 2005

Journal Articles

Autologous stem cell transplantation for HIV-infected individuals with relapsed lymphomas: no longer an experimental strategy

Cecilia Simonelli, Mariagrazia Michieli

Blood (2005) 105 (2): 439–440.

https://doi.org/10.1182/blood-2004-10-4050

Published: 2005

Journal Articles

High Dose Therapy (HDCT) with Autologous Stem Cell Transplantation (ASCT) for Non-Hodgkin Lymphoma in the Elderly: Feasibility of a Patient-Tailored Treatment Plan.

Maurizio Rupolo, MD, Mariagrazia Michieli, MD, Michele Spina, MD, Daniele Bernardi, MD, Massimiliano Berretta, MD, Annalisa Giacalone, Psic, Umberto Tirelli, MD

Blood (2004) 104 (11): 5216.

https://doi.org/10.1182/blood.V104.11.5216.5216

Published: 2004

Journal Articles

R-DHAOX as Salvage Regimen in Patients (pts) with Relapsed/Resistant Non-Hodgkin[spos]s Lymphoma (NHL).

Maurizio Rupolo, MD, Michele Spina, MD, Mariagrazia Michieli, MD, Massimiliano Berretta, MD, Luciano Abbruzzese, MD, Mario Mazzucato, MD, Valter Gattei, MD, Umberto Tirelli, MD

Blood (2004) 104 (11): 1323.

https://doi.org/10.1182/blood.V104.11.1323.1323

Published: 2004

Journal Articles

Ann Arbor Stage Is the Most Important Predictor of Survival for Refractory and Relapsed HIV-Associated Lymphoma Enrolled in a Program of High Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation.

Alessandro Re, MD, Chiara Cattaneo, MD, MariaGrazia Michieli, MD, Salvatore Casari, MD, Michele Spina, MD, Maurizio Rupolo, MD, Bernardino Allione, MD, Piero Ferremi, MD, Arnalda Lanfranchi, PhD, Mauro Mazzuccato, MD, Gianpiero Carosi, MD, Umberto Tirelli, MD, Giuseppe Rossi, MD

Blood (2004) 104 (11): 893.

https://doi.org/10.1182/blood.V104.11.893.893

Published: 2004

Journal Articles

Randomized Trial of Autologous Filgrastim-Primed Bone Marrow Transplantation Versus Filgrastim-Mobilized Peripheral Blood Stem Cell Transplantation in Lymphoma Patients

Daniela Damiani, Renato Fanin, Federico Silvestri, Stefania Grimaz, Laura Infanti, Antonella Geromin, Michela Cerno, Mariagrazia Michieli, Cristina Rinaldi, Chiara Savignano, Gabriella Trani, Mauro Fiacchini, Michele Baccarani

Blood (1997) 90 (1): 36–42.

https://doi.org/10.1182/blood.V90.1.36

Published: 1997

NARROW

A Simplified Geriatric Assessment (sGA) Can Identify Older Patients with Relapse/Refractory (R/R) Aggressive Lymphoma Suitable for Autologous Stem Cell Transplantation (ASCT): Final Results of Recanz Multicentre Prospective Phase 2 Study By the Fondazione Italiana Linfomi (FIL)

The Addition of Bortezomib to R-DHAP Does Not Improve the Response Pre-Stem Cell Transplantation Compared to Standard R-DHAP in Young Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Preliminary Results of the Phase II Randomized Trial FIL-VERAL12 of the Fondazione Italiana Linfomi

Management and Outcome of Patients with Diffuse Large B-Cell Lymphoma Relapsed after Autologous Hemopoietic Stem Cell Transplantation (auto-HSCT): A Retrospective Analysis of the Lymphoma Working Party (LWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Autologous Stem Cell Transplantation (autoSCT) for HIV-Associated Lymphoma in the Era of Combination Antiretroviral Therapy (cART): A Retrospective Analysis of the EBMT Lymphoma Working Party

Early Consolidation with High Dose Therapy and Autologous Stem Cell Transplantation in HIV-Associated Non Hodgkin Lymphoma at High Risk (aa-IPI 2-3). Mature Results of a Multicenter Prospective Phase II Trial

Early Consolidation with High Dose Therapy and Autologous Stem Cell Transplantation in HIV-Associated Non Hodgkin Lymphoma At High Risk (Aaipi 2–3). an Interim Report of a Multicenter Phase II Trial.

Peripheral Blood Stem Cell Mobilization In Hiv Positive Patients with Lymphoma Candidates to Autologous Transplantation: Predictive Factors Analysis for Failure or Suboptimal Stem Cell Collection

Pretransplatation PET as Major Prognostic Discriminant in IGEV (ifosfamide, gemcitabine, vinorelbine and prednisone) Treated Patients with Relapsed/Refractory Hodgkin's Lymphoma (HL).

High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors

Comparable survival between HIV + and HIV − non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation

High Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation as Salvage Therapy for HIV-Associated Lymphoma: Result of the GICAT Study.

Factors Affecting Outcome of Patients with Refractory/Relapsed Hodgkin’s Disease (HD) Treated with IGEV Chemotherapy (CT) and High Dose Consolidation Therapy (HDT) with Stem Cell Rescue.

Tymic Output after Autologous Bone Marrow Transplantation (ASCT) HIV-Related Lymphoma.

Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials

Autologous stem cell transplantation for HIV-infected individuals with relapsed lymphomas: no longer an experimental strategy

High Dose Therapy (HDCT) with Autologous Stem Cell Transplantation (ASCT) for Non-Hodgkin Lymphoma in the Elderly: Feasibility of a Patient-Tailored Treatment Plan.

R-DHAOX as Salvage Regimen in Patients (pts) with Relapsed/Resistant Non-Hodgkin[spos]s Lymphoma (NHL).

Ann Arbor Stage Is the Most Important Predictor of Survival for Refractory and Relapsed HIV-Associated Lymphoma Enrolled in a Program of High Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation.

Randomized Trial of Autologous Filgrastim-Primed Bone Marrow Transplantation Versus Filgrastim-Mobilized Peripheral Blood Stem Cell Transplantation in Lymphoma Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only